Community Redevelopment announced that Jeanne Freddura has joined the company as Senior Vice President of Finance and Development. Ms. Freddura will draw on her diverse background in business and finance as part of the Community Redevelopment team, as it continues to rapidly grow its business. Jeanne Freddura comes to Community Redevelopment with over 25 years of finance experience in a diverse set of industries, such as Pharmaceuticals, Biotechnologies, Research & Development, Retail, and High Technology.

Most recently, Jeanne worked as a financial consultant, providing broad spectrum support, to startup biotechs and established pharmaceutical companies. Prior to that, Jeanne was the Corporate Controller at Syntimmune, a clinical stage biotechnology company. Her leadership and expertise were instrumental in ensuring the $1.2 billion buyout of Syntimmune by Alexion Pharmaceuticals was completed accurately, efficiently, and within SEC guidelines.

Before that she was at Dicerna Pharmaceuticals where she participated in private placement, defining internal controls, and raising funds. In addition to leading financial projects and driving corporate development, Jeanne has also led finance teams in all aspects of development, financial management, long- and short-range strategic financial planning, process improvement, acquisitions, and achieving operational excellence. Throughout her career Jeanne has been a key contributor in helping corporations scale their business through streamlining finance and accounting operations, managing vendor relationships, and raising capital.

Jeanne is an expert in Initial Public Offering (IPO) readiness, mergers and acquisitions as well as SEC reporting (8K, 10-Q, 10-K), Proxy Statements, and maintaining Sarbanes Oxley compliance. Jeanne started her career in public accounting with Ernst and Young Brazil. She obtained a BA in Administration with concentration in Accounting from Cambridge College and recently completed her MS in Finance from Harvard University in Cambridge, MA.